Quarterly Transactions Made in Atea Pharmaceuticals, Inc. (AVIR)
This table provides information about the institutional ownership of Atea Pharmaceuticals, Inc. (AVIR). The information is specifically focused on institutions that hold shares of Atea Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 3,655,502 | 6,228,756 | 9,884,258 | 6,221,691 | 4,466,308 | 10,687,999 | -803,741 | |
Q4 2021 | 10,652,549 | 8,761,284 | 19,413,833 | 7,454,244 | 14,983,667 | 22,437,911 | -3,024,078 | |
Q1 2022 | 5,535,523 | 3,093,745 | 8,629,268 | 4,652,354 | 2,155,312 | 6,807,666 | 1,821,602 | |
Q2 2022 | 6,041,100 | 2,063,977 | 8,105,077 | 4,659,960 | 724,331 | 5,384,291 | 2,720,786 | |
Q3 2022 | 2,531,713 | 920,934 | 3,452,647 | 2,962,740 | 0 | 2,962,740 | 489,907 | |
Q4 2022 | 2,178,240 | 3,355,781 | 5,534,021 | 3,777,839 | 0 | 3,777,839 | 1,756,182 | |
Q1 2023 | 2,694,126 | 2,904,692 | 5,598,818 | 4,018,754 | 0 | 4,018,754 | 1,580,064 | |
Q2 2023 | 4,713,273 | 3,687,781 | 8,401,054 | 6,549,817 | 12,500 | 6,562,317 | 1,838,737 | |
Q3 2023 | 4,483,438 | 1,880,283 | 6,363,721 | 3,936,228 | 0 | 3,936,228 | 2,427,493 | |
Q4 2023 | 4,892,182 | 274,541 | 5,166,723 | 2,959,982 | 0 | 2,959,982 | 2,206,741 | |
Q1 2024 | 2,473,901 | 572,489 | 3,046,390 | 2,334,356 | 0 | 2,334,356 | 712,034 | |
Q2 2024 | 2,834,117 | 1,673,206 | 4,507,323 | 1,727,255 | 0 | 1,727,255 | 2,780,068 | |
Q3 2024 | 1,800,672 | 266,756 | 2,067,428 | 409,248 | 0 | 409,248 | 1,658,180 |